切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2025, Vol. 14 ›› Issue (01) : 87 -91. doi: 10.3877/cma.j.issn.2095-3232.2025018

临床研究

肝中心型肿瘤切除术后胆漏临床分析
李家军1, 万思乐1, 陆朝阳1,()   
  1. 1.150001 哈尔滨医科大学附属第一医院肝脏外科
  • 收稿日期:2024-11-18 出版日期:2025-02-10
  • 通信作者: 陆朝阳
  • 基金资助:
    国家自然科学基金(81972230)黑龙江省重点研发项目(2022ZX06C17)

Clinical analysis of bile leakage after surgical resection of central hepatic tumors

Jiajun Li1, Sile Wan1, Chaoyang Lu1,()   

  1. 1.Department of Hepatobiliary Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
  • Received:2024-11-18 Published:2025-02-10
  • Corresponding author: Chaoyang Lu
引用本文:

李家军, 万思乐, 陆朝阳. 肝中心型肿瘤切除术后胆漏临床分析[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 87-91.

Jiajun Li, Sile Wan, Chaoyang Lu. Clinical analysis of bile leakage after surgical resection of central hepatic tumors[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(01): 87-91.

目的

探讨肝中心型肿瘤切除术后胆漏的影响因素及防治措施。

方法

回顾性分析2017 年7 月至2023 年7 月在哈尔滨医科大学附属第一医院行肝部分切除术的148 例肝中心型肿瘤患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男54 例,女94 例;年龄25~75 岁,中位年龄50 岁。原发病:肝细胞癌27 例,肝血管瘤109 例,肝内胆管癌6 例,非典型增生结节4 例,肝包虫1 例,黑色素瘤1 例。根据术后有无胆漏将患者分为胆漏组和无胆漏组。采用单因素及Logistic多因素回归分析术后胆漏的危险因素。

结果

患者均顺利完成手术,手术时间中位数4.0(1.0~9.0)h,术中出血量248(10~4 000)ml。术后胆漏发生率10.8%(16/148),术后胆漏发生时间5.6(2.0~12.0)d,1 例采用腹腔引流联合胆管支架治愈,其余15 例均通过腹腔引流方式治愈。单因素分析显示,年龄、性别、术前AST、术前ALB、ICGR15、恶性肿瘤、糖尿病、病毒性肝炎、手术时间、术后TB、术后ALT、术后AST、术后ALB、术后活化部分凝血活酶时间(APTT)与术后胆漏发生有关(P<0.05)。Logistic 多因素回归分析显示,手术时间是肝中叶肿瘤切除术后胆漏的独立危险因素(OR=2.57,95%CI:1.33~4.97;P<0.05)。

结论

手术时间是肝中心型肿瘤切除术患者发生术后胆漏的独立危险因素,围手术期应积极改善患者基础状态,了解患者影像学资料,缩短手术时间。

Objective

To investigate the risk factors and preventive measures for bile leakage after surgical resection of central hepatic tumors.

Methods

Clinical data of 148 patients with central hepatic tumors who underwent partial hepatectomy in the First Affiliated Hospital of Harbin Medical University from July 2017 to July 2023 were retrospectively analyzed.The informed consents of all patients were obtained and the local ethical committee approval was received.Among them, 54 patients were male and 94 female,aged from 25 to 75 years, with a median age of 50 years.Primary diseases: 27 patients were diagnosed with hepatocellular carcinoma, 109 cases of hepatic hemangioma, 6 cases of intrahepatic cholangiocarcinoma,4 cases of atypical hyperplasia nodules, 1 case of hepatic echinococcosis and 1 case of melanoma.All patients were divided into the bile leakage and non-bile leakage groups according to the incidence of bile leakage after surgery.The risk factors of postoperative bile leakage were determined by univariate and multivariate Logistic regression analyses.

Results

All patients successfully completed procedures.The median operation time was 4.0(1.0-9.0) h, and intraoperative blood loss was 248(10-4 000) ml.The incidence of postoperative bile leakage was 10.8%(16/148), and the incidence time of bile leakage was 5.6(2.0-12.0) d after surgery.One patient was cured by abdominal drainage combined with biliary stent, and the remaining 15 cases were treated with abdominal drainage.Univariate analysis showed that age, gender, preoperative AST and ALB levels, ICGR15, malignant tumor, diabetes mellitus, viral hepatitis, operation time, postoperative TB, ALT, AST, ALB and activated partial thromboplastin time (APTT) levels were associated with the incidence of postoperative bile leakage (all P<0.05).Multivariate Logistic regression analysis revealed that operation time was an independent risk factor for bile leakage after surgical resection of central liver tumors(OR=2.57, 95%CI: 1.33-4.97, P<0.05).

Conclusions

Operation time is an independent risk factor for bile leakage in patients after surgical resection of central liver tumors.During perioperative period, extensive efforts should be made to improve basic status of patients, understand imaging data of patients and shorten operation time.

表1 胆漏组与无胆漏组肝中心型肿瘤肝部分除术患者围手术期指标比较
临床指标 胆漏组 无胆漏组 统计值 P
性别(例,男/女) 10/6 44/88 χ2=7.40 0.02
年龄(岁,xˉ±s 56±7 50±10 t=2.52 0.02
BMI(kg/m2xˉ±s 24.3±2.4 23.8±3.2 t=0.59 0.56
术前TB[μmol/L,MQ1Q3)] 14(9,16) 12(9,14) Z=1.12 0.26
术前ALT[U/L,MQ1Q3)] 21(14,45) 16(11,28) Z=1.61 0.12
术前AST[U/L,MQ1Q3)] 26(16,39) 17(14,23) Z=2.50 0.01
术前ALB[g/L,MQ1Q3)] 40(38,41) 41(39,43) Z=-2.50 0.01
术前APTT[s,MQ1Q3)] 27(26,28) 27(25,28) Z=0.44 0.66
术前Hb[g/L,MQ1Q3)] 136(129,144) 136(123,146) Z=0.33 0.74
ICGR15[MQ1Q3)] 0.074(0.047,0.088) 0.040(0.025,0.063) Z=2.82 0.01
恶性肿瘤(例) 11 24 χ2=21.02 <0.001
糖尿病(例) 5 5 χ2=17.08 <0.001
病毒性肝炎(例) 10 17 χ2=23.56 <0.001
肝脏手术史(例) 3 5 χ2=3.67 0.06
手术时间[h,MQ1Q3)] 6.8(5.6,8.0) 3.5(2.50,5.00) Z=5.05 <0.001
术中输血(例) 11 85 χ2=3.67 0.73
腹腔镜手术(例) 13 107 χ2=0 0.99
术后Hb[g/L,MQ1Q3)] 128(124,135) 124(112,135) Z=1.38 0.17
术后TB[μmol/L,MQ1Q3)] 29(16,42) 16(12,25) Z=3.37 <0.001
术后ALT[U/L,MQ1Q3)] 584(463,755) 296(180,454) Z=3.97 <0.001
术后AST[U/L,MQ1Q3)] 576(402,709) 229(127,382) Z=4.39 <0.001
术后ALB(g/L,xˉ±s 31±3 36±4 t=-4.37 <0.001
术后APTT[s,MQ1Q3)] 29(26,35) 26(25,28) Z=3.04 0.01
[1]
Bressem KK, Erxleben C, Lauscher JC, et al.Successful CTguided obliteration of isolated bile ducts with ethylene vinyl alcohol copolymer in a patient with chronic bile leakage after hepatectomy[J].J Vasc Interv Radiol, 2019, 30(10):1671-1673.
[2]
Shehta A, Farouk A, Said R, et al.Bile leakage after hepatic resection for hepatocellular carcinoma: does it impact the short- and long-term outcomes?[J].J Gastrointest Surg, 2022, 26(10):2070-2081.
[3]
Xue S, Wang H, Chen X, et al.Risk factors of postoperative bile leakage after liver resection: a systematic review and meta-analysis[J].Cancer Med, 2023, 12(14):14922-14936.
[4]
Martin AN, Narayanan S, Turrentine FE, et al.Clinical factors and postoperative impact of bile leak after liver resection[J].J Gastrointest Surg, 2018, 22(4):661-667.
[5]
Spetzler VN, Schepers M, Pinnschmidt HO, et al.The incidence and severity of post-hepatectomy bile leaks is affected by surgical indications, preoperative chemotherapy, and surgical procedures[J].Hepatobiliary Surg Nutr, 2019, 8(2):101-110.
[6]
Takasaki K.Glissonean pedicle transection method for hepatic resection: a new concept of liver segmentation[J].J Hepatobiliary Pancreat Surg, 1998, 5(3):286-291.
[7]
Tsui TY, Heumann A, Vashist YK, et al.How we do it: double in situ split for staged mesohepatectomy in patients with advanced gall bladder cancer and marginal future liver remnant[J].Langenbeck's Arch Surg, 2016, 401(4):565-571.
[8]
Harimoto N, Muranushi R, Hoshino K, et al.Albumin-Indocyanine Green Evaluation (ALICE) grade predicts bile leakage after hepatic resection[J].Surg Today, 2020, 50(8):849-854.
[9]
Nakagawa K, Tanaka K, Nojiri K, et al.Predictive factors for bile leakage after hepatectomy for hepatic tumors: a retrospective multicenter study with 631 cases at Yokohama Clinical Oncology Group (YCOG)[J].J Hepatobiliary Pancreat Sci, 2017, 24(1): 33-41.
[10]
Sadamori H, Yagi T, Shinoura S, et al.Risk factors for major morbidity after liver resection for hepatocellular carcinoma[J].Br J Surg, 2013,100(1):122-129.
[11]
Sadamori H, Yagi T, Matsuda H, et al.Intractable bile leakage after hepatectomy for hepatocellular carcinoma in 359 recent cases[J].Dig Surg, 2012, 29(2):149-156.
[12]
岳树强.肝切除术后胆漏的诊断与治疗[J/OL].中华肝脏外科手术学电子杂志, 2013, 2(2):128-130.
[13]
Yamashita YI, Yamamoto H, Miyata H, et al.Risk factors for bile leakage: latest analysis of 10 102 hepatectomies for hepatocellular carcinoma from the Japanese national clinical database[J].J Hepato Biliary Pancreat Sci, 2021, 28(7):556-562.
[14]
邓仲鸣, 孙权.肝切除术后并发胆漏危险因素及防治措施分析[J].中国临床研究, 2016, 29(2):204-206.
[15]
吴忠卫.肝胆手术后胆漏的相关因素分析[J].中国现代手术学杂志,2014, 18(4):260-262.
[16]
张胜龙, 杨先伟, 王文涛.泡型肝包虫病肝切除术后胆漏发生危险因素分析[J].中华普通外科杂志, 2020, 35(1):26-29.
[17]
Tuysuz U, Aktas H, Batı IB, et al.The role of Intraoperative cholangiography (IOC) and methylene blue tests in reducing bile leakage after living donor hepatectomy[J].Asian J Surg, 2021, 44(1):147-152.
[18]
Chiara O, Cimbanassi S, Bellanova G, et al.A systematic review on the use of topical hemostats in trauma and emergency surgery[J].BMC Surg, 2018, 18(1):68.
[19]
Zimmitti G, Vauthey JN, Shindoh J, et al.Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications[J].J Am Coll Surg,2013, 217(6):1028-1037.
[20]
Hayashi K, Abe Y, Shinoda M, et al.Clinical impact of intraoperative bile leakage during laparoscopic liver resection[J].Surg Endosc, 2021,35(8):4134-4142.
[21]
Chopinet S, Bollon E, Hak JF, et al.The white test for intraoperative screening of bile leakage: a potential trigger factor for acute pancreatitis after liver resection-a case series[J].BMC Surg, 2021,21(1):356.
[1] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[2] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[5] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[6] 吴哲境, 李敬东, 熊永福, 刘刚, 陈雷. 吲哚菁绿在解剖性肝切除术中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 25-29.
[7] 马子慧, 郭卫星. 腹腔镜肝尾状叶切除术的临床应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 36-40.
[8] 余承澍, 刘红枝, 林科灿, 林起柱, 黄霆峰, 周伟平, 程张军, 楼健颖, 郑树国, 毕新宇, 王剑明, 郭伟, 李富宇, 王坚, 郑亚民, 李敬东, 程石, 曾永毅. 肝内胆管细胞癌术后极早期复发的危险因素[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 53-59.
[9] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[10] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[11] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[12] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[13] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[14] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[15] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
阅读次数
全文


摘要